Skip to content

Development and Validation of the EFT for Adolescents With Cancer

Development and Validation of the Exercise Fit Test (EFT) for Adolescents With Cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05304988
Enrollment
400
Registered
2022-03-31
Start date
2020-09-07
Completion date
2025-12-31
Last updated
2025-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Adolescents, Physical Activity, Tool

Brief summary

There is increasing evidence of interventions shown to be effective to promote physical activity in adolescents with cancer. Nevertheless, adolescents with cancer become physically inactive after the end of the interventions. These interventions emphasized heavily on interventionists' role to assess adolescents' physical fitness and prescribe exercises. After the intervention, the adolescents were unable to follow the previous exercise prescriptions due to their changing medical conditions. To promote physical activity sustainably, it is vital to develop a patient-based assessment tool to allow adolescents with cancer to self-assess their own appropriate levels of physical activity that they could perform. However, a review of literature indicates a lack of such a tool.

Detailed description

A cross-sectional study design will be used. A convenience sample of 400 adolescents who (1) are aged 13-18; (2) are diagnosed with cancer; (3) can communicate in Cantonese and read Chinese will be recruited in Hong Kong Children's Hospital. The outcome measures will include demographic characteristics, pain scores, cardiopulmonary function measurements, EFT scores and ratings of the physiotherapists for the fitness of subjects for physical activity.

Interventions

OTHERTesting of the EFT

Our team will develop specific questions in EFT. Then, subject will be invited to fill in a set of questionnaires covering demographic characteristics, EFT items and a numerical rating scale for pain scores. The physiotherapists will rate the subject with the most appropriate level of physical activity.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Aged 13-18 * are diagnosed with cancer * are able to communicate in Cantonese and read Chinese

Exclusion criteria

Those with physical or cognitive impairments and learning problems, as identified from the medical records, were excluded. Also, those with medical advice that physical activity was not recommended or with detailed exercise prescriptions from physicians or physiotherapists during recruitment were excluded.

Design outcomes

Primary

MeasureTime frameDescription
The EFT scoresJust before their scheduled physiotherapists interviewSubjects will be asked to mark their responses for the EFT items in the second draft just before their scheduled oncologist routine visit. The scale ranges from 1 to 5. Higher scores indicate that the subjects are fit for a higher level of physical activity.

Secondary

MeasureTime frameDescription
Numerical Rating Scale (NRS) for painJust before their scheduled oncologist routine visitSubjects will be asked to mark their pain level on the NRS according to their experience just before their scheduled oncologist routine visit. The scale ranges from 0 to 10. Higher scores represent a higher level of pain.
The physiotherapists' rating for physical activityJust before their scheduled physiotherapist interviewThe physiotherapists will rate the subject with the most appropriate intensity level of physical activity on a 5-point scale. The scale ranges from 1 to 5. Higher scores indicate that the subjects are fit for a higher level of physical activity.

Countries

Hong Kong

Contacts

Primary ContactKatherine Lam, PhD
kwkatlam@polyu.edu.hk27666420
Backup ContactEva Ho, PhD
kyeva.ho@polyu.edu.hk27666417

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026